2024 Volume 50 - Canada Communicable Disease Report (CCDR)
Submit a manuscript
About CCDR
Browse
ISSN: 1481-8531
2024 Volume 50
CCDR Volume 50-12, December 2024: Tuberculosis
- Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on human papillomavirus (HPV) vaccines
- Popularity of HIV self-tests may say more about the state of our primary care system than about the device itself
- Mycobacterium tuberculosis pseudo-outbreak due to laboratory cross-contamination: A molecular epidemiology outbreak investigation
- Epidemiological analysis of paediatric tuberculosis infection in northern Saskatchewan First Nations communities, 2018–2022
- Bats and Rabies in Canada
- Thank you to the CCDR peer reviewers 2024
CCDR Volume 50-11, November 2024: Influenza Vaccination
- Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2024–2025
- Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older
- National Influenza Annual Report 2023–2024: A focus on influenza B and public health implications
- Perspectives on blastomycosis in Canada in the face of climate change
- Locally acquired typhoid fever outbreak linked to chronic carriage in Ottawa, Canada, 2018–2022
CCDR Volume 50-10, October 2024: COVID-19 after the pandemic
- Lessons learned from COVID-19: Harnessing community insights for better vaccination outcomes
- Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada
- Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19
- An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project
- Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021–September 2023
- Opportunities and lessons learned from a retrospective analysis of administrative billing data to understand the language profile of high-risk close contacts of COVID-19 cases in Ontario
CCDR Volume 50-9, September 2024: Health Risk Assessment
- Estimating public health risks of infectious disease events: A Canadian approach to rapid risk assessment
- Public health contributions of entomological surveillance of West Nile virus (WNV) and other mosquito-borne arboviruses in a context of climate change
- Human echinococcosis incidence in Canada: A retrospective descriptive study using administrative hospital and ambulatory visit data, 2000–2020
- Prevalence and correlates of oral antibiotic use in Canada
- Epidemiology of sporadic and outbreak-associated hepatitis A infections in Ontario, Canada: A descriptive summary, 2015–2022
CCDR Volume 50-7/8, July/August 2024: Sexual Health
- Summary of the National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) Statement: Recommendations on Screening for Syphilis in Non-Pregnant Adults and Adolescents
- Exploring the need for sexually transmitted infection education among university student athletes in Saskatchewan
- Acceptability, feasibility, equity and resource use for prenatal screening for chlamydia and gonorrhea: A systematic review
- HIV among African, Caribbean and Black people in Ontario
- Social capital interventions for human papillomavirus (HPV) immunization and cervical cancer screening: A rapid review
- Congenital rubella syndrome, a case series
CCDR Volume 50-6, June 2024: Cancer Vaccines
- Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018–2022
- Device and surgical procedure-related infections in Canadian acute care hospitals, 2018−2022
- Thematic description of factors linked with extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans
- Characteristics associated with SARS-CoV-2 testing, infection and vaccine uptake among essential non-healthcare workers in Montréal, 2021
CCDR Volume 50-5, May 2024: CCDR 50th Anniversary
- Canada Communicable Disease Report—50 years later
- Invasive pneumococcal disease surveillance in Canada, 2021–2022
- Invasive group A streptococcal disease surveillance in Canada, 2021–2022
- Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016–2022
- Outbreak of Human Trichinellosis — Arizona, Minnesota, and South Dakota, 2022
- An outbreak of Salmonella Infantis linked to shredded pork products from an unlicensed source in multiple health districts, Ontario, Canada, 2021
CCDR Volume 50-3/4, March/April 2024: Innovations in Public Health Surveillance
- Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy
- Innovations in public health surveillance: An overview of novel use of data and analytic methods
- Commentary on the adoption of a test-based versus syndromic-based approach to outbreak declaration and management in hospital and institutional settings
- Impact of the COVID-19 pandemic on inbound air travel to Canada
- Microbiology of bloodstream infections in Ontario, Canada during COVID-19 pandemic
CCDR Volume 50-1/2, January/February 2024: Respiratory Syncytial Virus (RSV)
- Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and people
- Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021–2022
- Disease burden attributable to respiratory syncytial virus outbreaks in long-term care
- PCV13, PCV15 or PCV20: Which vaccine is best for children in terms of immunogenicity?
- COVID-19 outcome trends by vaccination status in Canada, December 2020–January 2022
- National safety monitoring of vaccines from the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), 2018–2019
- Wastewater surveillance for COVID-19 in shelters: A creative strategy for a complex setting
- Evolution of illness severity in hospital admissions due to COVID-19, Québec, Canada, January to April 2022
- Epidemiological characteristics of human infections with avian influenza A(H5N6) virus, China and Laos: A multiple case descriptive analysis, February 2014–June 2023